Publications by authors named "Angeliki Befon"

Claim this Profile
L
Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study.
Alexander Katoulis, Evangelia Papadavid, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Irene Stefanaki, Angeliki Befon

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.
Irene Stefanaki, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, Pantelis Panagakis, Charitomeni Vavouli, Angeliki Befon

Int J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis.
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, Marina Papoutsaki, Maria Politou, Angeliki Befon

J Eur Acad Dermatol Venereol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, Charitomeni Vavouli, Ioannis-Alexios Koumprentziotis, Angeliki Befon

Int J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study.
Natalia Rompoti, Ioannis-Alexios Koumprentziotis, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Angeliki Befon

Arch Dermatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Total 25-Hydroxyvitamin D Levels in Patients With Cutaneous Malignant Melanoma: A Case-Control Study in a Low-Risk Southern European Population.
Angeliki Befon, Alexander C Katoulis, Sofia Georgala, Andreas Katsampas, Vasiliki Chardalia

Dermatol Pract Concept· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in Greece.
Angeliki Befon, Vassiliki Tzanetakou, Antonios Panagiotopoulos, Vasiliki Chasapi, Christina Antoniou

Int J Dermatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride.
Sofia Georgala, Alexander C Katoulis, Angeliki Befon, Ifigenia Danopoulou, Catherine Georgala

J Am Acad Dermatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study.
Sofia Georgala, Alexander C Katoulis, Angeliki Befon, Katerina Georgala, Panagiotis G Stavropoulos

Acta Derm Venereol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis